Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats

Abstract Background Pulmonary complications following renal ischemia-reperfusion injury (IRI) occur in a gender-dependent manner. Moreover, an imbalance in the renin-angiotensin system (RAS) exacerbates both renal and pulmonary diseases. Overactivation of the classical RAS component the angiotensin...

Full description

Saved in:
Bibliographic Details
Main Authors: Saeedeh Ahmadi, Samin Nahavandi, Aghdas Dehghani, Seyed Alireza Sobhani, Tuba Abbasi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-025-04323-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766430087577600
author Saeedeh Ahmadi
Samin Nahavandi
Aghdas Dehghani
Seyed Alireza Sobhani
Tuba Abbasi
author_facet Saeedeh Ahmadi
Samin Nahavandi
Aghdas Dehghani
Seyed Alireza Sobhani
Tuba Abbasi
author_sort Saeedeh Ahmadi
collection DOAJ
description Abstract Background Pulmonary complications following renal ischemia-reperfusion injury (IRI) occur in a gender-dependent manner. Moreover, an imbalance in the renin-angiotensin system (RAS) exacerbates both renal and pulmonary diseases. Overactivation of the classical RAS component the angiotensin type 1 receptor (AT1R) and angiotensin II may worsen renal IRI and remote organ damage, with gender-specific differences. This study aims to investigate the effect of renal IR on lung injury across genders. Methods Sixty Wistar rats (30 females, 30 males) were randomly assigned to three groups within each gender: Sham, IR (Isch), and IR with losartan (AT1R antagonist; Isch). Bilateral renal ischemia was induced for 45 min in all groups except the sham group. After 24 h of reperfusion, blood samples were collected for serum analysis, and kidney and lung tissues were harvested for histopathological examination, as well as assessment of malondialdehyde (MDA), and nitrite levels. The left lung was also weighed to evaluate pulmonary edema. Results Renal IR led to notable increases in plasma creatinine, blood urea nitrogen (BUN), MDA levels, and the extent of damage to the kidney and lung tissues in both genders. In female rats, losartan significantly decreased serum BUN (56.87 ± 13.1 vs. 112.9 ± 8.9 in groups Isch L and Isch), attenuated kidney scores (7.6 ± 1.3 vs. 12.8 ± 1.2 in groups Isch L and Isch), and increased renal (0.18 ± 0.02 vs. 0.10 ± 0.01 in groups Isch L and sham) and pulmonary nitrite concentrations (0.37 ± 0.07 vs. 0.22 ± 0.009 in groups Isch L and sham) following IR. On the other hand, serum MDA levels increased significantly in males treated with losartan (2.6 ± 0.11 vs. 3.9 ± 0.4 in groups sham and Isch L). Furthermore, losartan mitigated IR-induced lung injury in females (6.5 ± 0.6 vs. 8.3 ± 0.3 in groups Isch L and Isch), whereas it had no significant effect in males. Conclusions Our findings suggest that AT1R blockade with losartan confers a gender-dependent protective effect. Specifically, losartan may mitigate IR-induced renal and pulmonary damage in females, potentially through modulation of the nitric oxide pathway and attenuation of oxidative stress.
format Article
id doaj-art-f10e6aa53f0043d3b98eebbad4e8b3c4
institution DOAJ
issn 1471-2369
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj-art-f10e6aa53f0043d3b98eebbad4e8b3c42025-08-20T03:04:35ZengBMCBMC Nephrology1471-23692025-07-0126111110.1186/s12882-025-04323-9Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female ratsSaeedeh Ahmadi0Samin Nahavandi1Aghdas Dehghani2Seyed Alireza Sobhani3Tuba Abbasi4Endocrinology and Metabolism Research Center, Health institute, Hormozgan University of Medical SciencesStudent Research Committee, Faculty of Medicine, Hormozgan University of Medical SciencesEndocrinology and Metabolism Research Center, Health institute, Hormozgan University of Medical SciencesDepartment of Pathology, Faculty of Medicine, Hormozgan University of Medical SciencesDepartment of Pathology, Faculty of Medicine, Hormozgan University of Medical SciencesAbstract Background Pulmonary complications following renal ischemia-reperfusion injury (IRI) occur in a gender-dependent manner. Moreover, an imbalance in the renin-angiotensin system (RAS) exacerbates both renal and pulmonary diseases. Overactivation of the classical RAS component the angiotensin type 1 receptor (AT1R) and angiotensin II may worsen renal IRI and remote organ damage, with gender-specific differences. This study aims to investigate the effect of renal IR on lung injury across genders. Methods Sixty Wistar rats (30 females, 30 males) were randomly assigned to three groups within each gender: Sham, IR (Isch), and IR with losartan (AT1R antagonist; Isch). Bilateral renal ischemia was induced for 45 min in all groups except the sham group. After 24 h of reperfusion, blood samples were collected for serum analysis, and kidney and lung tissues were harvested for histopathological examination, as well as assessment of malondialdehyde (MDA), and nitrite levels. The left lung was also weighed to evaluate pulmonary edema. Results Renal IR led to notable increases in plasma creatinine, blood urea nitrogen (BUN), MDA levels, and the extent of damage to the kidney and lung tissues in both genders. In female rats, losartan significantly decreased serum BUN (56.87 ± 13.1 vs. 112.9 ± 8.9 in groups Isch L and Isch), attenuated kidney scores (7.6 ± 1.3 vs. 12.8 ± 1.2 in groups Isch L and Isch), and increased renal (0.18 ± 0.02 vs. 0.10 ± 0.01 in groups Isch L and sham) and pulmonary nitrite concentrations (0.37 ± 0.07 vs. 0.22 ± 0.009 in groups Isch L and sham) following IR. On the other hand, serum MDA levels increased significantly in males treated with losartan (2.6 ± 0.11 vs. 3.9 ± 0.4 in groups sham and Isch L). Furthermore, losartan mitigated IR-induced lung injury in females (6.5 ± 0.6 vs. 8.3 ± 0.3 in groups Isch L and Isch), whereas it had no significant effect in males. Conclusions Our findings suggest that AT1R blockade with losartan confers a gender-dependent protective effect. Specifically, losartan may mitigate IR-induced renal and pulmonary damage in females, potentially through modulation of the nitric oxide pathway and attenuation of oxidative stress.https://doi.org/10.1186/s12882-025-04323-9Losartan. Renal ischemic-reperfusion. Lung injury. Nitric oxide. AT1 receptor antagonist
spellingShingle Saeedeh Ahmadi
Samin Nahavandi
Aghdas Dehghani
Seyed Alireza Sobhani
Tuba Abbasi
Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
BMC Nephrology
Losartan. Renal ischemic-reperfusion. Lung injury. Nitric oxide. AT1 receptor antagonist
title Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
title_full Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
title_fullStr Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
title_full_unstemmed Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
title_short Role of AT1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia-reperfusion injury in male and female rats
title_sort role of at1angiotensin receptor antagonist in pulmonary complications induced by renal ischemia reperfusion injury in male and female rats
topic Losartan. Renal ischemic-reperfusion. Lung injury. Nitric oxide. AT1 receptor antagonist
url https://doi.org/10.1186/s12882-025-04323-9
work_keys_str_mv AT saeedehahmadi roleofat1angiotensinreceptorantagonistinpulmonarycomplicationsinducedbyrenalischemiareperfusioninjuryinmaleandfemalerats
AT saminnahavandi roleofat1angiotensinreceptorantagonistinpulmonarycomplicationsinducedbyrenalischemiareperfusioninjuryinmaleandfemalerats
AT aghdasdehghani roleofat1angiotensinreceptorantagonistinpulmonarycomplicationsinducedbyrenalischemiareperfusioninjuryinmaleandfemalerats
AT seyedalirezasobhani roleofat1angiotensinreceptorantagonistinpulmonarycomplicationsinducedbyrenalischemiareperfusioninjuryinmaleandfemalerats
AT tubaabbasi roleofat1angiotensinreceptorantagonistinpulmonarycomplicationsinducedbyrenalischemiareperfusioninjuryinmaleandfemalerats